to determine the immune status of persons receiving botulinum pentavalent ( abcde ) toxoid and to evaluate the effectiveness of the vaccine , we surveyed immunized individuals for neutralizing antibodies to type a and to type b botulinum toxins .
C0040555
toxoid
C0042210
vaccine